BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37968959)

  • 1. [Russian eligibility criteria prescribing menopausal hormonal hormones therapy for patients with cardiovascular and metabolic diseases. Consensus document of the Russian Cardiological Society, Russian Society of Obstetricians and Gynecologists, Russian Association of Endocrinologists, Eurasian Association of Therapists, Association of Phlebologists of Russia].
    Shlyakhto EV; Sukhikh GT; Serov VN; Dedov II; Arutyunov GP; Suchkov IA; Orlova YA; Andreeva EN; Yureneva SV; Yavelov IS; Yarmolinskaya MI; Villevalde SV; Grigoryan OR; Dudinskaya EN; Ilyukhin EA; Koziolova NA; Sergienko IV; Smetnik AA; Tapilskaya NI
    Probl Endokrinol (Mosk); 2023 Nov; 69(5):115-136. PubMed ID: 37968959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP].
    Shlyakhto EV; Sukhikh GT; Serov VN; Dedov II; Arutyunov GP; Suchkov IA; Orlova YA; Andreeva EN; Yureneva SV; Yavelov IS; Yarmolinskaya MI; Villevalde SV; Grigoryan OR; Dudinskaya EN; Ilyukhin EA; Koziolova NA; Sergienko IV; Smetnik AA; Tapilskaya NI
    Kardiologiia; 2023 Nov; 63(10):9-28. PubMed ID: 37970852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge and attitudes of health professionals regarding menopausal hormone therapies.
    Yeganeh L; Boyle J; Teede H; Vincent A
    Climacteric; 2017 Aug; 20(4):348-355. PubMed ID: 28379046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.
    Mendoza N; Ramírez I; de la Viuda E; Coronado P; Baquedano L; Llaneza P; Nieto V; Otero B; Sánchez-Méndez S; de Frutos VÁ; Andraca L; Barriga P; Benítez Z; Bombas T; Cancelo MJ; Cano A; Branco CC; Correa M; Doval JL; Fasero M; Fiol G; Garello NC; Genazzani AR; Gómez AI; Gómez MÁ; González S; Goulis DG; Guinot M; Hernández LR; Herrero S; Iglesias E; Jurado AR; Lete I; Lubián D; Martínez M; Nieto A; Nieto L; Palacios S; Pedreira M; Pérez-Campos E; Plá MJ; Presa J; Quereda F; Ribes M; Romero P; Roca B; Sánchez-Capilla A; Sánchez-Borrego R; Santaballa A; Santamaría A; Simoncini T; Tinahones F; Calaf J
    Maturitas; 2022 Dec; 166():65-85. PubMed ID: 36081216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the menopausal status of female gynecologists affect their prescription of menopausal hormone therapy?
    Vallejo MS; Witis S; Ojeda E; Mostajo D; Morera F; Meruvia N; Martino M; Lima S; Espinoza MT; Castillo O; Campostrini B; Danckers L; Blümel JE; Tserotas K; Sánchez H; Salinas C; Saavedra J; Rojas JA; Onatra W; Monterrosa A; Montaño A; Martínez J; González E; Gómez G; Calle A; Broutin G; Bencosme A; Arteaga E; Ayala F; Chedraui P
    Climacteric; 2016 Aug; 19(4):387-92. PubMed ID: 27327136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personal and professional use of menopausal hormone therapy among gynecologists: A multinational study (REDLINC VII).
    Danckers L; Blümel JE; Witis S; Vallejo MS; Tserotas K; Sánchez H; Salinas C; Saavedra J; Rojas JA; Onatra W; Ojeda E; Mostajo D; Morera F; Monterrosa A; Montaño A; Meruvia N; Martino M; Martínez J; Lima S; González E; Gómez G; Espinoza MT; Castillo O; Campostrini B; Calle A; Broutin G; Bencosme A; Arteaga E; Ayala F; Chedraui P
    Maturitas; 2016 May; 87():67-71. PubMed ID: 27013290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2017 hormone therapy position statement of The North American Menopause Society.
    Menopause; 2018 Nov; 25(11):1362-1387. PubMed ID: 30358733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing Bioidentical Menopausal Hormone Therapy: A Survey of Physician Views and Practices.
    Dubaut JP; Dong F; Tjaden BL; Grainger DA; Duong J; Tatpati LL
    J Womens Health (Larchmt); 2018 Jul; 27(7):859-866. PubMed ID: 29583064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts' perspective.
    Rozenberg S; Panay N; Gambacciani M; Cano A; Gray S; Schaudig K
    Expert Rev Clin Pharmacol; 2023; 16(6):507-517. PubMed ID: 37278023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.
    Huang WF; Tsai YW; Hsiao FY; Liu WC
    BMC Public Health; 2007 Apr; 7():56. PubMed ID: 17439639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline.
    Stuenkel CA; Davis SR; Gompel A; Lumsden MA; Murad MH; Pinkerton JV; Santen RJ
    J Clin Endocrinol Metab; 2015 Nov; 100(11):3975-4011. PubMed ID: 26444994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes and practices of gynecologists in Jaipur toward management of menopause.
    Meherishi S; Khandelwal S; Swarankar ML; Kaur P
    J Midlife Health; 2010 Jul; 1(2):74-8. PubMed ID: 21716769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Summary of the 2023 Thai Menopause Society Clinical Practice Guideline on Menopausal Hormone Therapy.
    Chaikittisilpa S; Orprayoon N; Vallibhakara O; Vallibhakara SA; Tanmahasamut P; Somboonporn W; Rattanachaiyanont M; Techatraisak K; Jaisamrarn U
    J Menopausal Med; 2024 Apr; 30(1):24-36. PubMed ID: 38714491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent gap in menopause care 20 years after the WHI: a population-based study of menopause-related symptoms and their management.
    Trémollieres FA; André G; Letombe B; Barthélemy L; Pichard A; Gelas B; Lopès P
    Maturitas; 2022 Dec; 166():58-64. PubMed ID: 36058119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
    Cobin RH; Goodman NF;
    Endocr Pract; 2017 Jul; 23(7):869-880. PubMed ID: 28703650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gynecologists are afraid of prescribing hormone replacement to endometrial/ovarian cancer survivors despite national guidelines-a survey in Sweden.
    Halldorsdottir S; Dahlstrand H; Stålberg K
    Ups J Med Sci; 2018 Dec; 123(4):225-229. PubMed ID: 30526173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between menopausal hormone therapy and sleep disturbance in women during the menopausal transition and post-menopause: data from the Norwegian prescription database and the HUNT study.
    Andenæs R; Småstuen MC; Misvær N; Ribu L; Vistad I; Helseth S
    BMC Womens Health; 2020 Mar; 20(1):64. PubMed ID: 32228557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 2017 hormone therapy position statement of The North American Menopause Society.
    The NAMS 2017 Hormone Therapy Position Statement Advisory Panel
    Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision hormone therapy: identification of positive responders.
    Kim YJ; Brinton RD
    Climacteric; 2021 Aug; 24(4):350-358. PubMed ID: 33615942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.